Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3,4-Diaminopyridine in LEMS
NCT02090725Phase 2Terminated
- Start
- Feb 2004
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifampridine in Lambert-Eaton myasthenic syndrome (LEMS). Started Feb 2004; status: terminated.
02
Drugs
amifampridine
03
Conditions
Lambert-Eaton myasthenic syndrome (LEMS)
Beyond the preview
Go deeper on NCT02090725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090725.